Inventor · disambiguated record
Werner Oberegger
Also filed as: OBEREGGER WERNER
19 granted patents·14 pending applications·826 citations·filing 2003–2024
96Inventor score
Files withBIOVAIL LAB INT SRL18TRIMEL PHARMACEUTICALS CORP3ACERUS BIOPHARMA INC2JACKSON GRAHAM2OBEREGGER WERNER2
Top patents by PatentIndex Score
33 records- 0198US7884136B2Modified-release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2006·Granted Feb 8, 2011·135 cites·4 claims
- 0298US7579380B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 25, 2009·135 cites·20 claims
- 0398US7569610B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 4, 2009·144 cites·5 claims
- 0498US7569611B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 4, 2009·141 cites·8 claims
- 0598US7241805B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2006·Granted Jul 10, 2007·79 cites·9 claims
- 0696US8932628B2Modified release formulations of a bupropion saltOBEREGGER WERNER·Filed 2007·Granted Jan 13, 2015·130 cites·10 claims
- 0792US7553992B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jun 30, 2009·11 cites·3 claims
- 0891US7585897B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Sep 8, 2009·9 cites·15 claims
- 0990US7572935B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Aug 11, 2009·7 cites·3 claims
- 1088US7662407B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Feb 16, 2010·5 cites·5 claims
- 1188US7645901B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jan 12, 2010·5 cites·3 claims
- 1288US7563823B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jul 21, 2009·6 cites·14 claims
- 1387US7649019B2Modified release formulations of a bupropion saltBIOVAIL LAB INT SRL·Filed 2007·Granted Jan 19, 2010·5 cites·3 claims
- 1486US7645802B2Bupropion hydrobromide and therapeutic applicationsBIOVAIL LAB INT SRL·Filed 2007·Granted Jan 12, 2010·7 cites·15 claims
- 1576US2025064831A1Controlled release topical testosterone formulations and methodsACERUS BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1675US10111888B2Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS SRL·Filed 2015·Granted Oct 30, 2018·2 cites·12 claims
- 1772US9504640B2Modified release formulations of a bupropion saltVALEANT PHARMACEUTICALS LUXEMBOURG S Á R L·Filed 2014·Granted Nov 29, 2016·1 cites·11 claims
- 1871US9757388B2Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gelsKREPPNER WAYNE·Filed 2012·Granted Sep 12, 2017·2 cites·42 claims
- 1971US7537784B2Modified release tablet of bupropion hydrochlorideBIOVAIL LAB INT SRL·Filed 2006·Granted May 26, 2009·2 cites·16 claims
- 2070US2009269402A1Modified release composition of at least one form of venlafaxineBIOVAIL LAB INT SRL·Filed 2009·Application pending·0 cites
- 2169US2011052684A1Pharmaceutical compositionBIOVAIL LAB INT SRL·Filed 2009·Application pending·0 cites
- 2268US2009246276A1Pharmaceutical CompositionsJACKSON GRAHAM·Filed 2009·Application pending·0 cites
- 2366US2015297733A1Controlled release topical testosterone formulations and methodsTRIMEL BIOPHARMA SRL·Filed 2013·Application pending·0 cites
- 2462US2007098797A1Modified release composition of at least one form of venlafaxineBIOVAIL LAB INT SRL·Filed 2006·Application pending·0 cites
- 2562US2010255094A1Bupropion hydrobromide and therapeutic applicationsBIOVAIL LAB INT SRL·Filed 2008·Application pending·0 cites
- 2657US2016113946A1Controlled release topical testosterone formulations and methodsTRIMEL BIOPHARMA SRL·Filed 2015·Application pending·0 cites
- 2753US2013266650A1Bupropion hydrobromide and therapeutic applicationsJACKSON GRAHAM·Filed 2013·Application pending·0 cites
- 2851US10668084B2Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS BIOPHARMA INC·Filed 2015·Granted Jun 2, 2020·0 cites·43 claims
- 2951US2013040922A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 3051US2013045958A1Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
- 3146US2016250228A1Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderACERUS PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 3244US2005238718A1Modified-release tablet of bupropion hydrochlorideOBEREGGER WERNER·Filed 2003·Application pending·0 cites
- 3342US2013040923A1Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorderTRIMEL PHARMACEUTICALS CORP·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →